Biotech Stock Roundup: SAGE, ATRA Down on Study Updates, AGIO Drug Approval & More - Nasdaq

Submitted by Anonymous (not verified) on Wed, 02/23/2022 - 17:57

Biotech Stock Roundup: SAGE, ATRA Down on Study Updates, AGIO Drug Approval & More  Nasdaq